Gwen A Melincoff's Net Worth
$1.94 Million
Who is Gwen A Melincoff?
Gwen A Melincoff has an estimated net worth of $1.94 Million. This is based on reported shares across multiple companies, which include COLLEGIUM PHARMACEUTICAL, INC, Protalix BioTherapeutics, Inc., SOLENO THERAPEUTICS INC, Gain Therapeutics, Inc., and Regado Biosciences Inc.
SEC CIK
Gwen A Melincoff's CIK is 0001614890
Past Insider Trading and Trends
2019 was Gwen A Melincoff's most active year for acquiring shares with 5 total transactions. Gwen A Melincoff's most active month to acquire stocks was the month of April. 2019 saw Gwen A Melincoff paying a total of $15,364.00 for 57,121 shares, this is the most they've acquired in one year.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
COLLEGIUM PHARMACEUTICAL, INC (COLL) Snapshot price: $33.26
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +27.99% | 9.79K |
—
|
—
| 44.77K |
May 18
| |||
Form 4
| +67.00% | 14.04K |
—
|
—
| 34.98K |
May 19
| |||
Form 4
| +90.32% | 9.94K |
—
|
—
| 20.95K |
May 20
| |||
Form 4
| +58.15% | 4.05K |
—
|
—
| 11.01K |
May 20
| |||
Form 4
| +208.92% | 4.71K |
—
|
—
| 6.96K |
Apr 25
| |||
Form 4
|
∞
| 2.25K |
—
|
—
| 2.25K |
May 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Protalix BioTherapeutics, Inc. (PLX) Snapshot price: $1.5
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
SOLENO THERAPEUTICS INC (SLNO) Snapshot price: $46.58
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25 - May 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 4
|
∞
| 10K |
$1.54 | $15,364.00 | 10K |
Nov 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Gain Therapeutics, Inc. (GANX) Snapshot price: $4.75
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Regado Biosciences Inc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||